MedPath

Effect of Mamsyadi kwatha ghana in the management of mild to moderate depression(vishaada)in adolescents

Phase 3
Conditions
Health Condition 1: F988- Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence
Registration Number
CTRI/2023/04/051925
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Participants showing signs of Mild to Moderate Depression as per DSM-V Criteria. (PHQ-9 score 5-14).

2. Participants whose caretakers/parents are willing to provide an informed consent.

3. Participants providing written informed assent to participate in the study

Exclusion Criteria

1. Patient having severe depression.

2. Patient having intelligent quotient below 70.

3. Patient having any severe co-morbid psychiatric disorder especially a diagnosis of bipolar disorder,schizophrenia, autism spectrum disorder, schizoaffective disorder or organic psychiatric disorder assessed by taking detailed history and examination.

4. Patient having any other medical or neurological conditions or any other illness interfering with interventions.

5. Participants suffering from any systemic illness, history of epilepsy or chronic illness like hypo or hyperthyroidism.

6. Substance use disorder or dependency, suicidal ideations.

7. Current use of Anti-epileptics, anti-psychotic or psychotropic drugs (e.g., Selective

Serotonin Reuptake Inhibitor, Serotonin and norepinephrine reuptake inhibitors etc.) and

any other investigational drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in the PHQ-9 score.Timepoint: 0week,8weeks,16weeks
Secondary Outcome Measures
NameTimeMethod
Improvement in sleep quality of adolescents as per PSQI scale <br/ ><br>Timepoint: 0week,8weeks,16weeks
© Copyright 2025. All Rights Reserved by MedPath